Point72 Asset Management L.P. Decreases Holdings in Centrus Energy Corp. (NYSE:LEU)

Point72 Asset Management L.P. lowered its stake in shares of Centrus Energy Corp. (NYSE:LEU) by 58.2% in the third quarter, Holdings Channel reports. The firm owned 62,023 shares of the company’s stock after selling 86,228 shares during the period. Point72 Asset Management L.P.’s holdings in Centrus Energy were worth $3,402,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of LEU. FMR LLC increased its stake in Centrus Energy by 79.3% during the 3rd quarter. FMR LLC now owns 426,249 shares of the company’s stock worth $23,380,000 after buying an additional 188,478 shares in the last quarter. Sara Bay Financial boosted its stake in shares of Centrus Energy by 3.9% in the second quarter. Sara Bay Financial now owns 337,201 shares of the company’s stock worth $14,415,000 after acquiring an additional 12,514 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Centrus Energy by 3.0% during the second quarter. Dimensional Fund Advisors LP now owns 297,708 shares of the company’s stock worth $12,727,000 after purchasing an additional 8,678 shares in the last quarter. Bank of New York Mellon Corp raised its stake in Centrus Energy by 382.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 222,607 shares of the company’s stock valued at $9,516,000 after purchasing an additional 176,431 shares during the last quarter. Finally, Goehring & Rozencwajg Associates LLC lifted its holdings in Centrus Energy by 18.6% in the 2nd quarter. Goehring & Rozencwajg Associates LLC now owns 204,093 shares of the company’s stock valued at $8,725,000 after purchasing an additional 32,000 shares in the last quarter. Institutional investors and hedge funds own 49.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on LEU. Roth Capital lowered shares of Centrus Energy from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 10th. B. Riley upped their price objective on shares of Centrus Energy from $88.00 to $126.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Finally, Roth Mkm decreased their target price on shares of Centrus Energy from $62.00 to $58.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $92.00.

Centrus Energy Stock Down 0.6 %

Shares of LEU opened at $78.29 on Monday. The stock has a fifty day simple moving average of $79.86 and a two-hundred day simple moving average of $55.69. The company has a quick ratio of 1.03, a current ratio of 1.63 and a debt-to-equity ratio of 1.44. The company has a market capitalization of $1.28 billion, a PE ratio of 16.34 and a beta of 1.12. Centrus Energy Corp. has a 52-week low of $33.51 and a 52-week high of $118.36.

Centrus Energy (NYSE:LEU) last released its quarterly earnings data on Monday, October 28th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.48). Centrus Energy had a return on equity of 138.38% and a net margin of 19.24%. The firm had revenue of $57.70 million for the quarter, compared to analyst estimates of $56.50 million. As a group, equities analysts forecast that Centrus Energy Corp. will post 2.28 EPS for the current year.

Centrus Energy Profile

Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.